Delivery Order SPE2DR25D9113-SPE2DR26FCHR6

The Defense Logistics Agency awarded a $5,633.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is scheduled for completion by November 18, 2025, with performance taking place at the vendor's Park Ridge facility.

This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition strategy designed to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. The PPV-G GEN V contract, awarded November 13, 2025, establishes a 30-month base period with three 30-month option periods and positions DMS Pharmaceutical Group as a critical pharmaceutical supplier for military medical operations globally. The company's established performance on numerous prior delivery orders demonstrates its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system.